Haptoglobin polymorphism in breast cancer patients form Jordan

Clinica Chimica Acta

Volumn 341, Issue 1-2, 2004, Pages 17-21

  Awadallah, Samir M ^a   Atoum, Manar F ^a  

^a HASHEMITE UNIVERSITY   (Jordan)

Author keywords

Breast Cancer; Electrophoresis; Haptoglobin; Jordan

Indexed keywords

HAPTOGLOBIN;

ADULT; ARTICLE; BREAST CANCER; CANCER GENETICS; CANCER PAIN; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; STATISTICAL SIGNIFICANCE;

EID: 1142297427     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2003.10.032     Document Type: Article

References (32)

1. Bowman B.H. Haptoglobin. Bowman B.H. Hepatic plasma proteins. 1993;159-167 Academic Press, San Diego.
2. Schultze H.E., Hermans J.F. Nature and metabolism of extracellular proteins. Schultze H.E., Hermans J.F. Molecular biology of human proteins. 1966;384-402 Elsevier, Amsterdam.
3. Langlois R.L., Delanghe J.R. Biological and clinical significance of haptoglobin polymorphism in humans. Clin. Chem. 42:1996;1589-1600.
4. Cid M.C., Grant D.S., Hoffman G.S., Auerbach R., Fauci A.S., Kleinman H.K. Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis. J. Clin. Invest. 91:1993;977-985.
5. Rantapää Dahlqvist S., Fröhlander N. Haptoglobin groups and rheumatoid arthritis. Hum. Hered. 35:1985;207-211.
6. Rantapää Dahlqvist S., Beckman G., Beckman L. Serum protein markers in systemic lupus erythromatosus. Hum. Hered. 38:1988;44-47.
7. Fröhlander N., Johnson O. Haptoglobin groups in acute myocardial infarction. Hum. Hered. 39:1989;345-350.
8. Chapelle J.P., Albert A., Smeets J.P., Heusghem C., Kulbertus H.E. Effect of haptoglobin phenotypes on the size of a myocardial infarct. N. Engl. J. Med. 307:1982;457-463.
9. Delanghe J., Duprez D., De Buyzere M.et al. Refractory hypertension is associated with the haptoglobin 2-2phenotype. J. Cardiovasc. Risk. 2:1995;131-136.
10. Nakhoul F.M., Zoabi R., Kanter Y.et al. Haptoglobin phenotype and diabetic nephropathy. Diabetologia. 44:2001;602-604.
11. Beckman G., Eklund A., Fröhlander N., Stjernberg N. Haptoglobin groups and lung cancer. Hum. Hered. 36:1986;258-260.
12. Benkmann H.G., Hanssen H.P., Ovenbeck R., Goedde H.W. Distribution of alpha-1-antitrypsin and haptoglobin phenotypes in bladder cancer patients. Hum. Hered. 37:1987;290-293.
13. John A., Henke J., Morich F.J. Identification of a so-far not characterized human serum protein associated with essential hypertension. Electrophoresis. 6:1985;292-295.
14. Tsamantanis C., Delinassios J.G., Kottaridis S., Christodoulou C. Haptoglobin types in breast carcinoma. Hum. Hered. 30:1980;44-45.
15. Bartel U., Elling D., Geserick G. Distribution of haptoglobin phenotypes in gynecologic tumors. Zentralbl. Gynakol. 107:1985;1492-1495.
16. Mitchell R.J., Carzino R., Janardhana V. Associations between the two serum proteins haptoglobin and transferring and leukemia. Hum. Hered. 38:1988;367-371.
17. Beckman G., Beckman L., Cedergren B., Göransson K., Liden S. Blood groups, serum groups and red cell enzyme types in allergic contact dermatitis. Hum. Hered. 31:1981;54-60.
18. Ames B.N., Gold L.S., Willett W.C. The causes and prevention of cancer. Proc. Natl. Acad. Sci. U. S. A. 92:1995;5258-5265.
19. Easton D.F. Familial risks of breast cancer. Breast Cancer Res. 4:2002;179-181.
20. Kamal M.F. Cancer patterns in Jordan 1975-1979. Ann. Chir. Gynaecol. 76:1987;191-196.
21. Kahan E., Ibrahim A.S., El Najjar K.et al. Cancer patterns in the Middle East-special report from the Middle East Cancer Society. Acta Oncol. 36(6):1997;631-636.
22. Bedwani R., Abdel-Fattah M., El-Shazly M.et al. Profile of familial breast cancer in Alexandria, Egypt. Anticancer Res. 21:2001;3011-3014.
23. Hudson B.L., Sunderland E., Cartwright R.A., Benson E.A., Smiddy F.G., Cartwright S.C. Haptoglobin phenotypes in two series of breast cancer patients. Hum. Hered. 32:1982;219-221.
24. Fröhlander N., Stendahl U. Haptoglobin groups in ovarian carcinoma. Hum. Hered. 38:1988;180-182.
25. Kaur H., Bhardwaj D.N., Shrivastava P.K., Sehajpal P.K., Singh J.P., Paul B.C. Serum protein polymorphisms in breast cancer. Acta Anthropog. 8:1984;189-197.
26. Akulenko L.V., Lunga I.N., Chudina A.P. The association of ovarian cancer with various genetic markers. Genetika. 25:1989;1125-1127.
27. Laemmili U.K. Cleavage and structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
28. Awadallah S., Hamad M. The prevalence of type II diabetes mellitus is haptoglobin phenotype-independent. Cytobios. 101:2000;145-150.
29. Weinberg E.D. The role of iron in cancer. Eur. J. Cancer Prev. 5:1996;19-36.
30. Reizenstein P. Iron, free radicals and cancer. Med. Oncol. Tumor Pharmacother. 8:1991;229-233.
31. Delanghe J.R., Langlois M.R., Boelaert J.R.et al. Haptoglobin polymorphism, iron metabolism and mortality in HIV infection. AIDS. 12:1998;1027-1032.
32. Delanghe J.R., Langlois M.R. Haptoglobin polymorphism and Body Iron Stores. Clin. Chem. Lab. Med. 40:2002;212-216.